A widely used in vitro fertilization (IVF) procedure, hailed for its potential to enhance the chances of successful pregnancy, may not actually improve the likelihood of healthy patients achieving a successful live birth, suggests new research published in the New England Journal of Medicine.
Focus on Preimplantation Genetic Testing for Aneuploidy (PGT-A)
The study zeroes in on Preimplantation Genetic Testing for Aneuploidy (PGT-A), a diagnostic procedure designed to screen embryos for chromosomal abnormalities that might hinder successful implantation. This testing has been a topic of controversy for decades, lacking definitive studies demonstrating its efficacy in improving the odds of achieving a live birth. An earlier version of the test, known as Preimplantation Genetic Screening (PGS), faced scrutiny in studies dating back to 2007, which indicated potential harm to patients' chances of having a child. Despite the lack of robust evidence, PGT-A has been widely offered to prospective parents globally, contributing to the multibillion-dollar reproductive medicine industry.
Provider Intentions and the Need for Evidence
While acknowledging that many providers may have good intentions, clinicians and researchers emphasize the crucial need for evidence-based practices in reproductive medicine. The study findings, challenging the efficacy of PGT-A, raise concerns about the procedure being offered to patients without strong supporting evidence, leading to increased costs and potential risks.
Hank Greely, Chair of the Steering Committee for the Stanford Center for Biomedical Ethics, points out the importance of weighing expectations and hopes against the available evidence. The current evidence supporting widespread PGT-A screening, he notes, is at best weak, prompting a reevaluation of its routine use in the realm of IVF.
As the industry grapples with evolving knowledge, the study adds to the ongoing conversation about the necessity of evidence-based approaches in reproductive medicine, ensuring that procedures offered to prospective parents are rooted in robust scientific validation.
Reference: New research casts further doubt on a common procedure used with IVF (statnews.com)
Add comment
Comments